Is the success rate of AIDS prevention drugs 100%? Response from listed companies: Existing patients require medication
海角七号
发表于 2024-6-24 18:18:35
224
0
0
On June 20th, Gilead Science announced that the top line results of the mid-term analysis of the critical Phase 3 PURPOSE 1 clinical trial showed that the twice administered injection of the HIV-1 capsid inhibitor lenacapavir (lenacapavir) demonstrated 100% effectiveness in HIV prevention studies targeting cisgender women.
According to 21st Century Business Herald reporters, this project is the most comprehensive and diverse HIV prevention clinical trial project to date.
On June 24, the share price of A-share AIDS drug listed companies fell sharply. As of the closing, Aidi Pharmaceutical fell more than 14%, and Frontier Biology fell more than 6%.
In this regard, the reporter of Nancai Express called Aidi Pharmaceutical as an investor, and relevant people said that Gilead Science did AIDS prevention for high-risk exposed groups in advance, while the company provided drugs for clinical trials of AIDS patients. When asked whether there will be no AIDS patients in the future, the above people said that according to the current test results, it may do some prevention, but there are still a large number of patients in stock who need medication.
The reporter also called Frontier Biology, but was not connected.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Google's parent company Alphabet CEO Pichai sells $3.29 million in stock
- Suddenly bearish! US January CPI exceeded expectations across the board!
- UBS will launch a new stock repurchase program worth up to $2 billion
- The HIV infection rate is 0! The effectiveness of the preventive drug Lenacapavir is yet to be determined. Long acting therapies may take off and reach a scale of 36.7 billion yuan by 2031
- Is the success rate of AIDS prevention drugs 100%? Response from listed companies: Existing patients require medication
- Nvidia CEO Huang Renxun sold approximately $27.6 million worth of Nvidia stock
- Boeing raises $21.1 billion through large-scale stock issuance
- Alibaba has repurchased a total of 135 million shares, accounting for 0.72% of the issued shares
-
知名做空机构香橼研究(Citron Research)周四(11月21日)在社交媒体平台X上发布消息称,该公司已决定做空“比特币大户”微策略(Microstrategy)这家公司,并认为该公司已经将自己变身成为一家比特币投资基金 ...
- caffycat
- 昨天 11:18
- 支持
- 反对
- 回复
- 收藏
-
每经AI快讯,11月20日,文远知行宣布旗下自动驾驶环卫车S6与无人扫路机S1分别在新加坡滨海湾海岸大道与滨海艺术中心正式投入运营。据介绍,这是新加坡首个商业化运营的自动驾驶环卫项目。 ...
- star8699
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
上证报中国证券网讯(记者王子霖)11月20日,斗鱼发布2024年第三季度未经审计的财务报告。本季度斗鱼依托丰富的游戏内容生态,充分发挥主播资源和新业务潜力,持续为用户提供高质量的直播内容及游戏服务,进一步 ...
- goodfriendboy
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
人民网北京11月22日电 (记者栗翘楚、任妍)2024广州车展,在新能源汽车占据“半壁江山”的同时,正加速向智能网联新能源汽车全面过渡,随着“端到端”成为新宠,智能驾驶解决方案成为本届广州车展各大车企竞 ...
- 3233340
- 昨天 17:06
- 支持
- 反对
- 回复
- 收藏